Evidence map›Paper›PMID 21750642›Full record

ArticleInternational journal of medical sciences2011

Enhancement of the click chemistry for the inverse Diels Alder technology by functionalization of amide-based monomers.

Ruediger Pipkorn, Manfred Wiessler, Waldemar Waldeck, Peter Lorenz, Ute Muehlhausen, Heinz Fleischhacker, Mario Koch, Klaus Braun

Abstract read
In one paragraph

Article in International journal of medical sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruediger PipkornGerman Cancer Research Center, Central Peptide Synthesis Unit, INF 580, 69120 Heidelberg, Germany. r.pipkorn@dkfz.de
Manfred Wiessler
Waldemar Waldeck
Peter Lorenz
Ute Muehlhausen
Heinz Fleischhacker
Mario Koch
Klaus Braun

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the near future personalized medicine with nucleic acids will play a key role in molecular diagnostics and therapy, which require new properties of the nucleic acids, like stability against enzymatic degradation. Here we demonstrate that the replacement of nucleobases with PNA by functional molecules harbouring either a dienophile or a diene reactivity is feasible and confers all new options for functionalization. These newly developed derivatives allow independent multi-ligations of multi-faceted components by use of the inverse Diels Alder technology. The high chemical stability and the ease of synthesis qualify these polyamide building blocks as favourites for intracellular delivery and targeting applications. This allows local drug concentrations sufficient for imaging and therapy and simultaneously a reduction of the application doses. It is important to point out that this technology is not restricted to ligation of medicament material; it is also a candidate to develop new and highly efficient active compounds for a "sustainable pharmacy".

Indexed as

AmidesMolecular StructurePeptide Nucleic AcidsSpectrometry, Mass, Electrospray IonizationAmidesPeptide Nucleic AcidsClick ChemistryDiels Alder Reactioninverse (DARinv)local concentrationPeptide Nucleic Acid (PNA)PNA building block functionalizationSustainable Pharmacy

Identifiers

PMID21750642
PMCPMC3133843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.